RxDoctor Payments Data

Helen Heslop, MD

Pediatric Hematology-Oncology · Houston, TXNPI 1912087271

Payments from drug & device makers

$51,344in general payments, 2019–2025

Across 30 payments — averaging $1711.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$28K
  • Novartis$14K
  • GSK$5K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • National Marrow Donor Program$2K
  • Autolus Inc$146
  • plus $119 from 2 others

What the payments were for

  • Consulting fees$46,85591%
  • Travel & lodging$2,9356%
  • Food & beverage$1,5343%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead(2 entities)10$27,835
Novartis8$14,137
GSK2$4,875
Takeda Pharmaceuticals U.S.A., Inc.1$2,500
National Marrow Donor Program6$1,733
Autolus Inc1$146
Pfizer1$94
Vertex1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,344 in reported general payments places this provider in the 70th percentile of 235 pediatric hematology-oncology providers in Texas.

See all pediatric hematology-oncology providers in Texas

Medicare billing

Part B allowed, 2024
$654
Medicare patients
21
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric hematology-oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →